Chemours (CC) Insider Trading & Ownership $11.46 -0.26 (-2.22%) As of 03:58 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Chemours (NYSE:CC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.34%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$251.57KNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$156.19K Get CC Insider Trade Alerts Want to know when executives and insiders are buying or selling Chemours stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CC Insider Buying and Selling by Quarter Chemours Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/3/2025Damian GumpelInsiderBuy7,822$9.95$77,828.90 6/2/2025Damian GumpelInsiderBuy13,400$9.22$123,548.00 5/19/2025Shane HostetterCFOBuy4,450$11.28$50,196.00 11/7/2024Alvenia ScarboroughSVPSell7,500$20.64$154,800.00 8/6/2024Diane I PichoInsiderSell73$19.04$1,389.92 (Data available from 1/1/2013 forward) CC Insider Trading Activity - Frequently Asked Questions Who is on Chemours' Insider Roster? The list of insiders at Chemours includes Alisha Bellezza, Alvenia Scarborough, Damian Gumpel, Diane I Picho, Mark Newman, Matthew S Abbott, and Shane Hostetter. Learn more on insiders at CC. What percentage of Chemours stock is owned by insiders? 0.34% of Chemours stock is owned by insiders. Learn more on CC's insider holdings. Which Chemours insiders have been buying company stock? The following insiders have purchased CC shares in the last 24 months: Damian Gumpel ($201,376.90), and Shane Hostetter ($50,196.00). How much insider buying is happening at Chemours? Insiders have purchased a total of 25,672 CC shares in the last 24 months for a total of $251,572.90 bought. Which Chemours insiders have been selling company stock? The following insiders have sold CC shares in the last 24 months: Alvenia Scarborough ($154,800.00), and Diane I Picho ($1,389.92). How much insider selling is happening at Chemours? Insiders have sold a total of 7,573 Chemours shares in the last 24 months for a total of $156,189.92 sold. More Insider Trading Tools from MarketBeat Related Companies Arcadium Lithium Insider Transactions Element Solutions Insider Transactions CSW Industrials Insider Transactions Avient Insider Transactions PureCycle Technologies Insider Transactions Perimeter Solutions Insider Transactions CVR Partners Insider Transactions Ingevity Insider Transactions Ecovyst Insider Transactions Tronox Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest3 Summer Stocks With Insider Buying and Analyst Support This page (NYSE:CC) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGold Shock (insane new prediction)World Gold Council reports: "No sign" of this catalyst slowing A whopping 73% of Americans report they're "...Stansberry Research | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Chemours Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemours With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
